Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Medical Ultrasound (Electronic Edition) ›› 2023, Vol. 20 ›› Issue (09): 930-938. doi: 10.3877/cma.j.issn.1672-6448.2023.09.007

• Abdominal Ultrasound • Previous Articles     Next Articles

Contrast-enhanced ultrasound versus gadoxetic acid-enhanced magnetic resonance imaging for LI-RADS classification of focal liver lesions ≤3 cm in patients at high risk of hepatocellular carcinoma: a prospective study

Jianmin Ding, Zhengyi Qin, Xiang Zhang, Yan Zhou, Hongyu Zhou, Yandong Wang, Xiang Jing()   

  1. Department of Ultrasound, The Third Central Hospital, Tianjin 300170, China;Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China
    Department of Radiology, The Third Central Hospital, Tianjin 300170, China;Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin 300170, China
  • Received:2022-06-24 Online:2023-09-01 Published:2023-12-11
  • Contact: Xiang Jing

Abstract:

Objective

To compare the consistency and diagnostic performance of contrast-enhanced ultrasound (CEUS) versus gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) in liver imaging reporting and data system (LI-RADS) classification of focal liver lesions ≤3 cm in patients at high risk of hepatocellular carcinoma (HCC).

Methods

Patients with focal liver lesions ≤3 cm at high risk of HCC who underwent CEUS and EOB-MRI at Tianjin Third Central Hospital were prospectively collected. The CEUS and EOB-MRI images of each liver nodule were observed to evaluate interobserver consistency using kappa coefficient and category according to the CEUS LI-RADS V2017 and CT/MRI LI-RADS V2018 criteria in a double blind manner. Pathology was used as the reference standard of malignant lesions and pathology and/or follow-up results were used as the reference standard for benign lesions to calculate the diagnostic performance of the two modalities, and χ2 test and Z test were used to compare the difference between the two modalities.

Results

A total of 114 nodules of 107 cases met the inclusion criteria. The proportions of LR-5, LR-4, LR-3, and LR-M diagnosed by CEUS and EOB-MRI accounted for 45.6%, 11.4%, 19.3%, and 23.7%, and 25.4%, 57.9%, 10.5%, and 6.1%, respectively. The consistency of nodule classification between the two modalities was poor (Kappa=0.17, P<0.001). There was good consistency between readers on CEUS LI-RADS and EOB-MRI LI-RADS (Kappa=0.83 and 0.77, P<0.001). The positive predictive values of CEUS and EOB-MRI LR-5, LR-4, and LR-3 for HCC were 98.1%, 38.5%, and 13.6%, and 100%, 71.2%, and 16.7%, respectively. The sensitivity, specificity, and area under the curve (AUC) of CEUS and EOB-MRI LR-5 for HCC were 64.6%, 97.1%, and 0.81, and 36.7%, 100%, and 0.68, respectively. The was no statistical difference in the positive predictive value or specificity between the two groups, while the difference of AUC was statistically significant (Z=4.29, P<0.01).

Conclusion

CEUS and EOB-MRI have poor consistency in classification of liver nodules ≤ 3 cm. The consistency between readers is good. CEUS and EOB-MRI LR-5 have equally good diagnostic performance for HCC ≤ 3 cm.

Key words: Hepatocellular carcinoma, Contrast-enchanced ultrasound, EOB-MRI, LI-RADS

Copyright © Chinese Journal of Medical Ultrasound (Electronic Edition), All Rights Reserved.
Tel: 010-51322630、2632、2628 Fax: 010-51322630 E-mail: csbjb@cma.org.cn
Powered by Beijing Magtech Co. Ltd